F-group (family)
9.1.1.5 Triabin
Ligands and drugs
12
Member domains
6
with ligand contacts (≤ 4 Å)
50.0% of members
6
with DrugDomain annotations
50.0% of members
6
with a DrugBank compound
50.0% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 9.1.1.5 belongs to X-group 9 Lipocalins/Streptavidin, which binds 9.3 ligand superclasses per 20 proteins, broader than 86% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00143 | GSH | Glutathione | 2 |
| DB08841 | AEF | Tyramine | 1 |
| DB08855 | LTX | Leukotriene C4 | 1 |
| DB11858 | LTD | Leukotriene D4 | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| EAH | (5S,7E,9E,11Z,14Z)-5-hydroxyicosa-7,9,11,14-tetraenoic acid | 2 |
| GSH | Glutathione | 2 |
| AEF | 4-(2-aminoethyl)phenol | 1 |
| LTD | (5~{S},6~{R},7~{E},9~{E},11~{Z},14~{Z})-6-[(2~{R})-2-azanyl-3-(2-hydroxy-2-oxoethylamino)-3-oxidanylidene-propyl]sulfanyl-5-oxidanyl-icosa-7,9,11,14-tetraenoic acid | 1 |
| LTX | (5~{S},6~{R},7~{E},9~{E},11~{Z},14~{Z})-6-[(2~{R})-2-[[(4~{S})-4-azanyl-5-oxidanyl-5-oxidanylidene-pentanoyl]amino]-3-(2-hydroxy-2-oxoethylamino)-3-oxidanylidene-propyl]sulfanyl-5-oxidanyl-icosa-7,9,11,14-tetraenoic acid | 1 |